This fund primarily allocates capital to equity investments, specifically common and preferred shares, across companies of all market capitalizations. Under typical market conditions, at least 80% of its net assets, along with any borrowed capital used for investment, will be directed toward firms predominantly active in the healthcare industry. These healthcare companies are defined as those primarily involved in the research, development, production, or distribution of healthcare-related products and services. The portfolio maintains a non-diversified investment approach.

Eli Lilly and Company

Legend Biotech Corporation

Gilead Sciences, Inc.

Rhythm Pharmaceuticals, Inc.

Intuitive Surgical, Inc.

AbbVie Inc.

Abivax S.A.

Insmed Incorporated

Revolution Medicines, Inc.

Boston Scientific Corporation

Healthcare

Harbor Health Care ETF (MEDI)

MEDI Holdings & Sector Breakdown

MEDI Holdings & Sector Breakdown